Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2017
As of Jul 31, 2016
Q1 FY2017
As of Apr 30, 2016
Q4 FY2016
As of Jan 31, 2016
Q3 FY2016
As of Oct 31, 2015
Q2 FY2016
As of Jul 31, 2015
Q1 FY2016
As of Apr 30, 2015
Q4 FY2015
As of Jan 31, 2015
Q3 FY2015
As of Oct 31, 2014
Q2 FY2015
As of Jul 31, 2014
Q1 FY2015
As of Apr 30, 2014
Q4 FY2014
As of Jan 31, 2014
Q3 FY2014
As of Oct 31, 2013
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts receivable, net
Inventory
Other current assets
Total current assets
Property and equipment, net
Other assets
Total assets
Liabilities and Stockholders' Deficit
Current liabilities:
Short-term borrowings
Line of credit
Accounts payable
Accrued liabilities
Deferred revenue
Total current liabilities
Convertible senior notes, net
Deferred revenue
Long-term liabilities
Other long-term liabilities
Total liabilities
Stockholders' deficit:
Preferred stock, $0.0001 par value, 10,000 shares authorized as of July 31, 2016; no shares issued and outstanding as of July 31, 2016 and January 31, 2016
Common stock, $0.0001 par value, 250,000 shares authorized as of July 31, 2016; 25,165 and 24,660 shares issued and outstanding as of July 31, 2016 and January 31, 2016, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders' deficit
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support